SILO Relative Valuation
SILO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SILO is overvalued; if below, it's undervalued.
Historical Valuation
Silo Pharma Inc (SILO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.21. The fair price of Silo Pharma Inc (SILO) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：0.45
Fair
-0.65
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Silo Pharma Inc. (SILO) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-0.02
EV/EBIT
Silo Pharma Inc. (SILO) has a current EV/EBIT of -0.02. The 5-year average EV/EBIT is 0.36. The thresholds are as follows: Strongly Undervalued below -0.62, Undervalued between -0.62 and -0.13, Fairly Valued between 0.85 and -0.13, Overvalued between 0.85 and 1.35, and Strongly Overvalued above 1.35. The current Forward EV/EBIT of -0.02 falls within the Historic Trend Line -Fairly Valued range.
84.28
PS
Silo Pharma Inc. (SILO) has a current PS of 84.28. The 5-year average PS is 46.73. The thresholds are as follows: Strongly Undervalued below -38.02, Undervalued between -38.02 and 4.35, Fairly Valued between 89.10 and 4.35, Overvalued between 89.10 and 131.47, and Strongly Overvalued above 131.47. The current Forward PS of 84.28 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Silo Pharma Inc. (SILO) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.62. The thresholds are as follows: Strongly Undervalued below -2.16, Undervalued between -2.16 and -1.39, Fairly Valued between 0.14 and -1.39, Overvalued between 0.14 and 0.91, and Strongly Overvalued above 0.91. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Silo Pharma Inc. (SILO) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Silo Pharma Inc (SILO) has a current Price-to-Book (P/B) ratio of 0.94. Compared to its 3-year average P/B ratio of 0.84 , the current P/B ratio is approximately 12.86% higher. Relative to its 5-year average P/B ratio of 2.77, the current P/B ratio is about -65.93% higher. Silo Pharma Inc (SILO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -68.98%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -46.41% , the current FCF yield is about -100.00% lower.
0.94
P/B
Median3y
0.84
Median5y
2.77
-79.08
FCF Yield
Median3y
-68.98
Median5y
-46.41
Competitors Valuation Multiple
The average P/S ratio for SILO's competitors is , providing a benchmark for relative valuation. Silo Pharma Inc Corp (SILO) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 0.00%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SILO decreased by 49.27% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -5.15K to -6.16K.
The secondary factor is the Revenue Growth, contributed 0.00%to the performance.
Overall, the performance of SILO in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Silo Pharma Inc (SILO) currently overvalued or undervalued?
What is Silo Pharma Inc (SILO) fair value?
How does SILO's valuation metrics compare to the industry average?
What is the current P/B ratio for Silo Pharma Inc (SILO) as of Dec 05 2025?
What is the current FCF Yield for Silo Pharma Inc (SILO) as of Dec 05 2025?
What is the current Forward P/E ratio for Silo Pharma Inc (SILO) as of Dec 05 2025?